InflaRx (IFRX) Other Non Operating Income (2017 - 2026)

InflaRx's (IFRX) quarterly Other Non Operating Income came in at $576454.1 in Q1 2026, up 128.71% year-on-year from $252046.1 in Q1 2025, and up 1047.55% quarter-over-quarter from -$60836.4 in Q4 2025.

InflaRx (IFRX) Other Non Operating Income (2017 - 2026) Analysis & Trends

InflaRx has disclosed Other Non Operating Income across 10 years of filings, most recently posting $576454.1 for Q1 2026.

  • Other Non Operating Income for Q1 2026 came in at $576454.1, up 128.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $571322.8 (up 601.81% YoY), and the FY2025 annual result was -$5.6 million, down 244.01% from the prior year.
  • Other Non Operating Income came in at $576454.1 for Q1 2026 at InflaRx, up from -$60836.4 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $889.7 billion in Q3 2022 to a low of -$1220.7 billion in Q1 2023.
  • The 5-year median for Other Non Operating Income is $766109.7 (2024), against an average of -$19.5 billion.
  • Across the five-year window, Other Non Operating Income surged 105394589.14% in 2022 and tumbled 149417763.85% in 2023, its largest moves.
  • InflaRx's Other Non Operating Income stood at -$746398.7 in 2022, then sank by 132.09% to -$1.7 million in 2023, then surged by 345.64% to $4.3 million in 2024, then slumped by 101.43% to -$60836.4 in 2025, then soared by 1047.55% to $576454.1 in 2026.
  • The last three Other Non Operating Income figures came in at $576454.1 (Q1 2026), -$60836.4 (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40

Historic Data

Download Data
DateValue
Mar 31, 2026 576,454.08
Dec 31, 2025 -60,836.41
Sep 30, 2025 3.30 Mn
Jun 30, 2025 -3.25 Mn
Mar 31, 2025 -2.01 Mn
Dec 31, 2024 4.26 Mn
Sep 30, 2024 -3.13 Mn
Jun 30, 2024 766,109.67
Mar 31, 2024 1.98 Mn
Dec 31, 2023 -1.73 Mn
Sep 30, 2023 2.50 Mn
Jun 30, 2023 835,908.45
Mar 31, 2023 -1,220.72 Bn
Dec 31, 2022 -746,398.69
Sep 30, 2022 889.67 Bn
Jun 30, 2022 1.67 Mn
Mar 31, 2022 816,986.66
Dec 31, 2021 2,246.91 Bn
Sep 30, 2021 844,132.69
Jun 30, 2021 -995,093.10